Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: CIOMS XIV Draft “Artificial Intelligence in Pharmacovigilance”
Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: Outcome of GVP Inspections by NPRA
Posted on May 5, 20255/5/25
Staying Ahead of the Curve in Pharmacovigilance: Emerging Regulations and Their Implications in Saudi Arabia
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 3, 20246/3/24
Updated Guidance May Ease MDR Transition for SaMD Manufacturers
Posted on February 26, 20242/26/24
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Posted on February 21, 20242/21/24
The Looming Legacy of Software as a Medical Device (SaMD) Misclassification Under Medical Device Directive (MDD)
Posted on November 7, 202311/7/23
The Data-Driven Revolution: AI’s Impact on Pharmaceutical Quality in Digital Therapy
Posted on October 31, 202310/31/23
Unveiling the Future: AI Opportunities in FDA Compliance, Insights from the OPQ Symposium
Posted on August 24, 20238/24/23